DEMİRTAŞ, B. And DİKMEN, M. 2013. Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line. The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma , (Barcelona, Spain), 3.

DEMİRTAŞ, B., & DİKMEN, M., (2013). Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line . The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma (pp.3). Barcelona, Spain

DEMİRTAŞ, BUKET, And MİRİŞ DİKMEN. "Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line," The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma, Barcelona, Spain, 2013

DEMİRTAŞ, BUKET And DİKMEN, MİRİŞ. "Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line." The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma , Barcelona, Spain, pp.3, 2013

DEMİRTAŞ, B. And DİKMEN, M. (2013) . "Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line." The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma , Barcelona, Spain, p.3.

@conferencepaper{conferencepaper, author={BUKET DEMİRTAŞ And author={MİRİŞ DİKMEN}, title={Evaluated of Anti Cancerogenic Effects of Pazopanib A New Tyrosine Kinase Inhibitor on A549 Lung Cancer Cell Line}, congress name={The 1st International Congress on Controversies in Personelized Oncology Treatment Breast, Colon, Lung and Melanoma}, city={Barcelona}, country={Spain}, year={2013}, pages={3} }